Mobile Health Technology for Palliative Care Patients

Mobile Health Technologies for Palliative Care Patients at the Interface of In-patient to Out-patient Care: A Feasibility Study Aiming to Early Predict Deterioration of Patient's Health Status

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03038841

Enrollment

Registered

2017-02-01

Start date

2017-02-01

Completion date

2018-05-31

Last updated

2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease, Metastatic Cancer, Mobile Health

Brief summary

To test the potential and acceptance of wireless activity tracking in palliative care patients leaving hospital care. Explorative study, collaboration project of the Clinic of Radiation-Oncology, University Hospital Zurich and the Wearable Computing Laboratory, Swiss Federal Institut of Technology. Patients receive a tracking bracelet and a smart phone in order to gather objective physical activity parameters as step count, sleep duration, heart rate, social activity patterns (e.g. making calls) as well as subjective ratings of pain and distress. Quality of life (QoL) will be captured by paper questionnaire. Correlations between patients' physical activity patterns and the pain and distress level assessed from electronic scales as well as QoL-questionnaire will be performed. Acceptance will be evaluated by quantitative questionnaires and interviews. The proposed study is meant to be preparatory work for an intervention study to test the effect of wireless monitoring of palliative care patients on fostering early interventions for symptom relief and support of QoL.

Interventions

DEVICEMobile Health

Patients discharged from hospital will be equipped with a tracking bracelet and a smart phone

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 105 Years

Healthy volunteers

Inclusion criteria

* established diagnosis of metastatic cancer or other severe illness with limited life-expectancy (physicians guess \<12 months, \> 8 weeks) * Karnofsky Index ≥50% * ECOG≤ 2 * aged \> 18 years * passed a short handling test with devices (tracking bracelet, smart phone)

Exclusion criteria

* relevant cognitive impairment * insufficient knowledge of German language.

Design outcomes

Primary

Measure	Time frame	Description
Feasibility (time of complete data transfer in weeks)	12 weeks	time of complete data transfer in weeks

Countries

Switzerland

Contacts

Primary ContactGudrun Theile, MD

gudrun.theile@usz.ch+41 44 255 5495

Backup ContactMatea Pavic, MD

matea.pavic@usz.ch+41 44 255 3015

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026